LNSR - NASDAQ

LENSAR, Inc.

LNSR·NASDAQ

$5.57

-4.9%

HealthcareMedical - Devices

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$67.42M

EPS-2.8700

P/E Ratio-1.94

Earnings Date08/06/2026

lnsr

Other Current Liabilities

Last Annual Value

15.05M

3-Year CAGR

62%

5-Year CAGR

38%

10-Year CAGR

22%

Adjust for Inflation

LENSAR, Inc. Competitors Analysis of Other Current Liabilities

LNSR · NASDAQ

Company	Other Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
LENSAR, Inc. NASDAQ:LNSR	15.05M	55.4%	34.9%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	7.58M	14.5%	38.7%	38.8%
TriSalus Life Sciences, Inc. NASDAQ:TLSI	8.23M	169.6%	139.7%	N/A
Sight Sciences, Inc. NASDAQ:SGHT	9.21M	26.7%	9.0%	N/A
Apyx Medical Corporation NASDAQ:APYX	8.21M	74.5%	31.1%	12.2%
Hyperfine, Inc. NASDAQ:HYPR	5.89M	26.5%	53.1%	N/A
Lucid Diagnostics Inc. NASDAQ:LUCD	-865.39M	N/A	N/A	N/A
AVITA Medical, Inc. NASDAQ:RCEL	9.80M	168.6%	94.2%	20.2%
Spero Therapeutics, Inc. NASDAQ:SPRO	5.58M	20.1%	N/A	4.2%
Rapid Micro Biosystems, Inc. NASDAQ:RPID	8.32M	18.9%	15.5%	N/A
Owlet, Inc. NYSE:OWLT	-94.00K	N/A	N/A	N/A

LENSAR, Inc. Fair Value Envelope

LNSR · NASDAQ

Our analysis suggests that LNSR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.57, this represents a potential HIDDEN relative to our calculated worth for LENSAR, Inc..

HIDDEN

Intrinsic Value

Current Price: $5.57

Related Guides

Blog Categories

Continue your LNSR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.